According to a report from Deloitte Touche Tohmatsu, chemical companies’ profits will continue to fall unless new approaches are adopted. The report is based on the analysis of 1998–2008 financial results for 231 publicly held chemical firms. Gross margins for 35 commodity-chemical providers declined from 28% in 1998 to 16.5% in 2007. Commodity-chemical suppliers are […]
Global R&D spending is expected to grow 4.0% in 2010 to $1,156.5 billion, following a 1.0% decline in 2009, according to Battelle and R&D Magazine. China’s R&D spending rose 21.0% to account for 11.1% of worldwide R&D spending in 2009, while R&D expenditures in India increased 5.2% to account for 2.5%. R&D spending in Asia […]
Sydney, Australia 12/9/09—NuSep, a publicly-listed maker of pre-casts gels and systems for bioseparations, has signed a letter of intent to acquire BioInquire, the developer of the ProteoIQ software for MS data analysis. BioInquire projects a profit of $1.2 million for 2010. The purchase price consists of an initial payment of $1.5 million; a $1 million […]
Belfast, Northern Ireland 12/23/09—Andor Technology, a developer of digital cameras, has acquired Bitplane AG for £7.46 million ($11.95 million) in cash and the issue of 285,851 shares at the price of 2 pence each ($0.03). Based in Zurich, Switzerland, Bitplane develops microscopy image analysis software for medical and life science applications. In 2008, Bitplane had […]
Los Angeles, CA 11/9/09—LC column developer and supplier Phenomenex has filed suit against Thermo Fisher Scientific in the US District Court for the Central District of California, alleging false advertising and unfair competition. The action is in connection with an email sent in October by a Thermo Fisher product manager to US distributors. Phenomenex seeks […]
Boston, MA 12/2/09; Boston, MA 12/29/09—Thermo Fisher Scientific has filed suit against Innov-X Systems, a developer and manufacturer of X-ray Fluorescence (XRF) systems. The suit filed in US District Court for the District of Massachusetts charges Innov-X with false advertising, unfair competition, deceptive trade practices, intentional interference with business relations, product disparagement and business defamation. […]
Brussels, Belgium 12/22/09—Dow Jones has reported that the European Commission (EC) extended the deadline for its antitrust review of Agilent’s acquisition of Varian (see IBO 7/31/09) by 10 working days to January 20. By that date, the EC will either clear the acquisition or launch an investigation. The extension was due to “commitments” by Agilent […]
Washington, DC 12/18/09; London, England 12/18/09—Diversified technology firm Danaher has announced a £50 million ($82 million) offer, net of cash acquired, for publicly held Genetix, a maker of research and clinical diagnostic instruments. In 2009, Genetix generated revenues of £26 million ($42 million) (see IBO 3/15/09). Danaher proposes to acquire all the issued and to […]
This month, President Obama signed the US Department of Health and Human Services’ (HHS) appropriations bill for fiscal 2010, starting October 1, 2009 (see IBO 12/15/09). The HHS budget increased 5.3% to $803.5 billion The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC), both part of the HHS, benefited […]
In 2009, the world economic downturn exposed a fragile and unregulated global financial system. Virtually every economy was impacted by the collapse of the financial system, as the Morgan Stanley Capital International (MSCI) All-Country World Index fell 24.1% during the first quarter of 2009. However, a concerted effort by international governments to support the credit […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
